Update date
31 Dec 2024
Shareable Research Card
TC BioPharm (Holdings) plc Accrued Liabilities, Current
This metric view shows TC BioPharm (Holdings) plc accrued liabilities, current history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2024
- Latest reported value
- £1,011,943
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2024
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2024.
- Latest reported value on this page: £1,011,943.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Accrued Liabilities, Current
Latest reported accrued liabilities, current: £1,011,943. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2024
SEC-backed company facts were refreshed from filings filed on 09 May 2025.
Benchmark Context
How Accrued Liabilities, Current compares with peers
TC BioPharm (Holdings) plc sits in the bottom quarter of the current accrued liabilities, current sample.
Compared with
Compared with 2 companies reporting accrued liabilities, current in GBP. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.6x the current sample midpoint. Accrued Liabilities, Current is down about 18% versus the comparable prior period.
- Visible rows currently span reported period ends from 27 Sep 2022 to 31 Dec 2024.
- Nearby companies in this sample: REVELATION BIOSCIENCES, INC..
- Current sample position: rank #2 of 2 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
TC BioPharm (Holdings) plc: Accrued Liabilities, Current
Latest period: Q4 2024. Period end: 31 Dec 2024. Units: GBP. Frequency: quarterly.
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Metric snapshot
- Latest value
- £1,011,943
- Coverage range
- 31 Dec 2022 - 31 Dec 2024
- Fact rows
- 5
What this metric tells you
- Shows reported accrued liabilities, current over 31 Dec 2022 - 31 Dec 2024.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 5 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Accrued Liabilities, Current levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
TC BioPharm (Holdings) plc appears at rank #2 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | REVELATION BIOSCIENCES, INC. (revb) | £1,600,000 | Instant - 27 Sep 2022 | Open REVELATION BIOSCIENCES, INC. Accrued Liabilities, Current |
| 2 | TC BioPharm (Holdings) plc | £1,011,943 | Instant - 31 Dec 2024 | Open TC BioPharm (Holdings) plc Accrued Liabilities, Current |
Metric Details
- Metric
- Accrued Liabilities, Current (AccruedLiabilitiesCurrent)
- Frequency coverage
-
quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- us-gaap
- Units tracked
- GBP
- History range
-
31 Dec 2022 - 31 Dec 2024
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
5
Source: SEC company facts API
- Metric definition
-
Carrying value as of the balance sheet date of obligations incurred payable pertaining to costs that are statutory in nature are incurred on contractual obligations accumulate over time for which invoices have not yet been received or will not be rendered. Examples include taxes interest rent utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Accrued Liabilities, Current, Quarterly (GBP)
Accrued Liabilities, Current, YoY Quarterly Change (%)
TC BioPharm (Holdings) plc Quarterly Accrued Liabilities, Current (GBP)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | £1,011,943 | -£217,476 | -18% | 31 Dec 2024 | 20-F | 09 May 2025 | 2024 | FY |
| Q2 2024 | £915,268 | 30 Jun 2024 | 6-K | 25 Nov 2024 | 2024 | Q2 | ||
| Q1 2024 | £1,013,162 | 31 Mar 2024 | 10-Q | 15 May 2024 | 2024 | Q1 | ||
| Q4 2023 | £1,229,419 | +£284,515 | +30% | 31 Dec 2023 | 20-F | 09 May 2025 | 2024 | FY |
| Q4 2022 | £944,904 | 31 Dec 2022 | 10-K | 01 Apr 2024 | 2023 | FY |
* marks a reported value that did not pass the local value check.